Ray Chaudhuri, K
Qamar, Mubasher A http://orcid.org/0000-0002-4105-5097
Rajah, Thadshani
Loehrer, Philipp
Sauerbier, Anna
Odin, Per
Jenner, Peter
Article History
Received: 23 May 2016
Revised: 7 July 2016
Accepted: 25 August 2016
First Online: 1 December 2016
Competing interests
: K Ray Chaudhuri has received honorarium for sponsored symposium lectures AbbVie, UCB, Britannia, US Worldmeds, GSK, Teva pharmaceuticals, Mundipharma, and Bial. P Loehrer is supported by the Koeln Fortune Program/Faculty of Medicine, University of Cologne and the Konrad-Adenauer-Foundation. A Sauerbier is supported by a BRC grant as well as an innovation grant from Parkinson’s UK and Kirby Laing Foundation. She has received grants or honoraria from Bial, UCB, Britannia, Merz, and Global Kinetics. P Jenner has received speakers fees and consultancy fees from Britannia Pharmaceuticals, UCB, Lundbeck, Teva, Worldwide Clinical Trials, Chronos Therapeutics, Kyowa Hakko, FP Pharmaceuticals, Adamas, Abbvie, and BIAL. P Odin has received honoraria for lectures and expert advice from AbbVie, Britannia, Nordic Infucare, UCB, and Zambon. The remaining authors declare no conflict of interest.